<DOC>
	<DOCNO>NCT00476359</DOCNO>
	<brief_summary>To evaluate pharmacokinetics ( PK ) LPV/r saquinavir HIV-1 infected child . To evaluate treatment response ( clinical , immunological virological ) LPV/r , SQV Thai child .</brief_summary>
	<brief_title>A PK Salvage Study Children With HIV-infection</brief_title>
	<detailed_description>The PK 24 week data publish Pediatric Infectious Diseases Journal . It show plasma drug concentration saquinavir , lopinavir ritonavir high limit expect range adult treatment approve dosage ( 1000/100 mg BID saquinavir , 400/100 mg BID lopinavir/r ) . The regimen well tolerate show significant CD4 rise VL decline 48 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>1 . Confirmed HIV1 infection HIVDNA PCR &lt; 18 month old HIV ELISA great equal 18 month old 2 . Subject less equal 16 year age day first dose . 3 . Subject fail current NRTI and/or NNRTI contain regimen na√Øve protease inhibitor contain therapy . 4 . Results biochemistry haematology test within prespecified range . 5 . Subject able swallow capsule 6 . Caretaker ( ) is/are able willing sign Informed Consent Form prior screen evaluation . 1 . History sensitivity/idiosyncrasy lopinavir , ritonavir , saquinavir chemically related compound excipients may employ trial . 2 . Relevant history current condition might interfere drug absorption , distribution , metabolism excretion . 3 . Inability child caregiver ( ) understand nature extent trial procedure require . 4 . Use concomitant medication , include drug list , may interfere pharmacokinetics LPV/r SQV . NNRTIs Rifampicin Rifabutin Phenobarbital Phenytoine Carbamazepine Dexamethasone Ketoconazole Clarithromycin 5 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Lopinavir/r</keyword>
	<keyword>Saquinavir</keyword>
	<keyword>Dual boost PIs</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>HIV child</keyword>
	<keyword>C min</keyword>
	<keyword>Second line HAART</keyword>
	<keyword>ARV</keyword>
	<keyword>VL failure</keyword>
	<keyword>Dosage</keyword>
	<keyword>To evaluate treatment response</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>